PMVP
PMV Pharmaceuticals, Inc.
Biotechnology · Healthcare · United States
1.31
close · 2026-10-30
value
23
cheaper than peers23
quality
75
stronger fundamentals75
ranked against
Biotechnology (pre-revenue)
value
quality
109 peerswide variation
Value inputs
| measure | company | vs peers |
| EV to EBITDA | 0.16× | 94 |
| price to book | 0.98× | 79 |
| earnings yield, 3 years ago | -122.9% | 36 |
| earnings yield, 2 years ago | -109.9% | 32 |
| earnings yield, 1 year ago | -87.0% | 25 |
| cash flow yield, 1 year ago | -52.5% | 23 |
| cash flow yield, 2 years ago | -57.2% | 22 |
| earnings yield, latest year | -113.0% | 18 |
| cash flow yield, latest year | -74.4% | 17 |
| cash flow yield, 3 years ago | -72.5% | 17 |
10 of 12 measures available
Quality inputs
| measure | company | vs peers |
| debt to equity | 0.3% | 90 |
| operating margin | 0.0% | 50 |
| return on equity | -70.9% | 48 |
3 of 4 measures available
Facts
| market cap | $99M |
| free cash flow | -$43.8M |
| employees | 54 |
| first trade | 2020-09-25 |
| next earnings | 2026-08-14 |
| fundamentals updated | 2026-08-28 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | -1.48 | -1.14 | -1.44 | -1.61 |
| free cash flow | -$73.6M | -$51.9M | -$56.6M | -$71.7M |
| net income | -$77.7M | -$58.7M | -$69.0M | -$73.3M |
| revenue | $0 | $0 | $0 | $0 |